Cannabis: Good for your health?

IN THIS DAY AND AGE, where political correct-ness and morality rule, society in general has become more informed about most topics, be it cancer...

The Matrix – DECODING THE NHS

THE PRESCRIBING ADVISERS in Primary care represent one of the industry’s biggest challenges. In the second part of this topic, Omar Ali explores some...

Group Therapy for the Uninitiated

The selling process is changing; an increasing number of customer contacts are now being made in group situations. However, many sales people are concerned...

The joys of independence

IT IS NOT ALWAYS REALISED that some of the big-name pharmaceutical companies such as Boehringer Ingelheim, Napp Pharmaceuticals and Servier are still privately-owned. This...

Cultural Intelligence

HAVE YOU EVER WONDERED why we select candidates for Medical Representative positions largely on their personality and potential ability to develop relationships with customers...

First Line Management Development

  Getting your first line management role can be quite a challenge. Most first line managers will have spent several years being developed for...

Better Brains!

Most people in life never actively and deliberately use their brains. Sounds a strange statement to make but...

Compliance? Who Cares…..?

Are regulations negotiable?Who are the MHRA? Currently these are issues for all of us working in the pharma and...

New GP GMS contract – How to help practices increase quality and income

Paul Midgley of the Healthcare Partnership looks at the new GP GMS contract and examines how a ‘yes’ vote will help medical representativeswork more...

Tenders and Proposals

Preparing proposals is enough to make most people cringe. They take far too long to prepare, they’re absolutely boring...

Latest articles

Image of brain scan to show People with neurological conditions lose out due to COVID-19 delays

People with neurological conditions lose out due to COVID-19 delays

In a recent survey of more than 1600 people with neurological conditions, over 7 in 10 respondents said they had experienced delays to their...
Image of a head with a cloud brain to show Post COVID-19 mental health crisis awaits

Without support for services post COVID-19 mental health crisis awaits

The BMA is warning that we could face a post COVID-19 mental health crisis if urgent support not provided for services. The BMA says...
healthcare professionals in PPE to show Major study into COVID-19 long-term health effects

Major study into COVID-19 long-term health effects

The Health and Social Care Secretary has announced the launch of a major £8.4m research study into the long-term health effects of COVID-19 on...

Popular articles

Image of a person descending a ladder over coronavirus to show New Normal, New Thinking: Life Post COVID-19

New Normal, New Thinking: Life Post COVID-19

New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
Image of a head with a cloud brain to show Post COVID-19 mental health crisis awaits

Without support for services post COVID-19 mental health crisis awaits

The BMA is warning that we could face a post COVID-19 mental health crisis if urgent support not provided for services. The BMA says...
Image of a scale held by a hand with one business person on the left and a group balancing on the right to show Crisis or crossroads? Where next for key account management post-COVID?

Crisis or crossroads? Key account management post-COVID

Miranda Wheatley Price from Rubica calls for a dynamic response to the current challenge as she explores the future for key account management post-COVID. One...
Image of brain scan to show People with neurological conditions lose out due to COVID-19 delays

People with neurological conditions lose out due to COVID-19 delays

In a recent survey of more than 1600 people with neurological conditions, over 7 in 10 respondents said they had experienced delays to their...
Image of a scientist at their lab to show Study shows existing anti-parasitic drug kills coronavirus within 48 hours

Study shows anti-parasitic drug ivermectin kills coronavirus within 48 hours

A collaborative study led by the Monash Biomedicine Discovery Institute (BDI) with the Peter Doherty Institute of Infection and Immunity (Doherty Institute), a joint...

Subscribe

Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription